4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-06-015127
Chief Financial Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CULPEPPER PETER R · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2006-10-30 | Exercise or conversion : show line 1 in the form | +3,500 | $1.10 | $3,850 | 62,081 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2006-10-30 | Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) | −3,500 | $1.10 | 2014-02-25 | 3,500 | 237,919 | D |
Loading xslF345X02/doc1.xml…